Preclinical and dose-ranging assessment of hESC-derived dopaminergic progenitors for a clinical trial on Parkinson's disease
2023 · Cell stem cell · 43 citations
https://doi.org/10.1016/j.stem.2023.11.009
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3
Papers
56
Citations
3
h-index
1
i10-index
Jang Hyeon Eom is an academic researcher from Bio-Medical Science (South Korea). The author has contributed to research in topics: Pluripotent Stem Cells Research & Parkinson's Disease Mechanisms and Treatments & CRISPR and Genetic Engineering. The author has an h-index of 3, co-authored 3 publications.
https://doi.org/10.1016/j.stem.2023.11.009
https://doi.org/10.1016/j.stem.2024.01.006
Click to start Chat